Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Receivables (2016 - 2025)

Prestige Consumer Healthcare has reported Receivables over the past 15 years, most recently at $190.5 million for Q4 2025.

  • For Q4 2025, Receivables rose 13.86% year-over-year to $190.5 million; the TTM value through Dec 2025 reached $190.5 million, up 13.86%, while the annual FY2025 figure was $194.3 million, 9.91% up from the prior year.
  • Receivables for Q4 2025 was $190.5 million at Prestige Consumer Healthcare, down from $199.0 million in the prior quarter.
  • Over five years, Receivables peaked at $199.0 million in Q3 2025 and troughed at $114.7 million in Q1 2021.
  • A 5-year average of $160.1 million and a median of $161.0 million in 2023 define the central range for Receivables.
  • Biggest five-year swings in Receivables: decreased 23.82% in 2021 and later increased 21.68% in 2025.
  • Year by year, Receivables stood at $134.3 million in 2021, then rose by 17.0% to $157.1 million in 2022, then rose by 10.95% to $174.3 million in 2023, then dropped by 4.02% to $167.3 million in 2024, then grew by 13.86% to $190.5 million in 2025.
  • Business Quant data shows Receivables for PBH at $190.5 million in Q4 2025, $199.0 million in Q3 2025, and $168.4 million in Q2 2025.